oru.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Laboratory Medicine.
Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Laboratory Medicine.ORCID-id: 0000-0003-2317-5738
Vise andre og tillknytning
2018 (engelsk)Inngår i: OncoTarget, ISSN 1949-2553, E-ISSN 1949-2553, Vol. 9, nr 27, s. 18786-18796Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Cervical cancer (CC) is one of the most common cancers in women and virtually all cases of CC are a result of a persistent infection of human papillomavirus (HPV). For disease detected in early stages there is curing treatment but when diagnosed late with recurring disease and metastasis there are limited possibilities. Here we evaluate HPV impact on treatment resistance and metastatic disease progression. Prevalence and distribution of HPV genotypes and HPV16 variants in a Swedish CC patient cohort (n=209) was evaluated, as well as HPV influence on patient prognosis. Tumor samples suitable for analysis (n=204) were genotyped using two different real-time PCR methods. HPV16 variant analysis was made using pyrosequencing. Results showed that HPV prevalence in the total series was 93%. Of the HPV-positive samples, 13% contained multiple infections, typically with two high-risk HPV together. Primary cure rate for the complete series was 95%. Recurrence rate of the complete series was 28% and distant recurrences were most frequent (20%). Patients with tumors containing multiple HPV-strains and particularly HPV genotypes belonging to the alpha 7 and 9 species together had a significantly higher rate of distant tumor recurrences and worse cancer-specific survival rate.

sted, utgiver, år, opplag, sider
Impact Journals LLC , 2018. Vol. 9, nr 27, s. 18786-18796
Emneord [en]
HPV, cervical cancer, recurrences, survival
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-71672DOI: 10.18632/oncotarget.24666PubMedID: 29721161Scopus ID: 2-s2.0-85045206587OAI: oai:DiVA.org:oru-71672DiVA, id: diva2:1281568
Tilgjengelig fra: 2019-01-22 Laget: 2019-01-22 Sist oppdatert: 2019-01-24bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Kaliff, MalinHelenius, GiselaKarlsson, Mats G.Lillsunde-Larsson, Gabriella

Søk i DiVA

Av forfatter/redaktør
Kaliff, MalinHelenius, GiselaKarlsson, Mats G.Lillsunde-Larsson, Gabriella
Av organisasjonen
I samme tidsskrift
OncoTarget

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 135 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf